Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Industry Recognition

31 Jan 2006 07:02

Sopheon PLC31 January 2006 Embargoed Release: 07:00hrs Tuesday 31st January 2006 Sopheon Plc ('Sopheon' or the 'Company') Leading IT Market Research Firm Cites Sopheon As First-Mover In Taking Advantage of Major Market Trend New Report Says Company Well-Positioned to Benefit From Convergence of Product Life Cycle and Portfolio Management Solutions Sopheon Plc, the international software and services company, announces todaythat global IT research and advisory firm IDC has published a profile analyzingSopheon and its flagship Accolade process and product portfolio managementsystem. The report credits Sopheon with early recognition of the convergence ofproduct life cycle management (PLM) and project portfolio management (PPM)solutions and taking effective action to capitalize on this trend, which IDCcharacterizes as a major, new market force. (Source: IDC, "Sopheon's AccoladeBreaking out in PLM and Portfolio Management Convergence," Doc #34274.) In an IDC Product Flash, analysts Evan Quinn and Gisela Wilson examine Sopheon'smarket position and the evolution of its flagship offering. From the analysts'perspective, Accolade's functional focus on improving the product developmentprocess, including recent enhancements to the solution, has separated it fromtraditional project portfolio management software and is positively impactingSopheon's business outlook. The report observes that Sopheon seems "particularly well positioned to ride thePLM/PPM convergence trend given its differentiated approach." Earmarks of thatapproach, according to IDC's analysis, include built-in support for the widelyused Stage-Gate(R) product development process framework; portals and analyticstargeted for process industries; integration with Microsoft(R) Project; andstrong portfolio management features. The commentary points to Sopheon'sexpanding sales pipeline, increasing deal size and its stepped-up pursuit ofindirect channel sales partnerships as validation that the company is movinginto a new phase of growth. "Sopheon stands out as a first mover in PLM/PPM convergence," the reportconcludes, "and possesses a position of leverage in Microsoft's businessapplication partnership community. Accolade is ahead of many of its moreestablished competitors in terms of how to leverage collaboration, portal, andcontent technologies for innovation management." "Generic project management tools can provide great value operationally," saidAndy Michuda, chief executive officer of Sopheon, "But they don't address theneeds of corporate executives for information that can help them make strategicproduct-development decisions. There's a growing body of evidence that one ofthe most important characteristics separating innovation leaders from the packis that they put in place a strong product innovation process and support itwith superior project management skills. Accolade enables organizations toquickly develop these capabilities as a sustainable competitive advantage. Oursolution was built from the ground up to manage projects within the businesscontext of the new product development process. And it has demonstrated that itcan produce break-through results. Being recognized as a "first-mover" in thisemerging market of applying project management best-practices to the productlife cycle management process is strong validation of our unique application andstrategic focus. Having this recognition come from one of the world's topindependent IT research and advisory firms is especially affirming." Sopheon Accolade(R) is a registered trademark of Sopheon plc. Stage-Gate(R) is a registered trademark of the Product Development Institute. Microsoft(R) is a registered trademark of Microsoft Corporation.All other trademarks and registered trademarks are the soleproperty of their respective owners. About Sopheon Sopheon (LSE: SPE) is an international provider of software and services thathelp organizations improve the business impact of product development. TheSopheon Accolade(R) product development system automates gate- or phase-basedproduct development processes and provides strategic decision support thatallows companies to improve innovation, cut product development spending wasteand shorten time-to-market. Sopheon's Monitor software operates as a "readingrobot" that automatically reviews, filters, analyzes and pushes relevant contentto healthcare and engineering professionals to enable effective compliance withprotocols, standards and regulations. Sopheon is listed on the AIM Market of theLondon Stock Exchange and on the Euronext in the Netherlands. For moreinformation, please visit www.sopheon.com. For further information contact: Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100Andrew Tan + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Apr 20167:00 amRNSDirectors Options and Shareholding
21st Mar 20167:00 amRNSAmendment to Terms of Convertible Loan Stock
17th Mar 20167:00 amRNSFinal Results
21st Jan 20168:29 amRNSAccolade Release 10.2
8th Jan 20167:00 amRNSTrading Update and Board Change
20th Oct 20159:33 amRNSDirector Dealing
19th Oct 20157:00 amRNSDirector Dealing
9th Oct 20153:41 pmRNSDirector Dealing
9th Oct 20151:12 pmRNSDirector Dealing
2nd Oct 20153:39 pmRNSDirector Dealing
23rd Sep 20157:00 amRNSAccolade Release 10.1
27th Aug 20157:01 amRNSHalf Yearly Report
1st Jul 20157:00 amRNSDirector Shareholding
10th Jun 20151:44 pmRNSResult of AGM
10th Jun 20157:00 amRNSAGM Statement
2nd Jun 20157:00 amRNSAccolade 10.0 release
15th May 20153:10 pmRNSNotice of AGM
7th May 201511:40 amRNSDIRECTOR SHAREHOLDING
23rd Apr 201511:10 amRNSDirector Shareholding
20th Apr 201511:43 amRNSDirector Shareholding
13th Apr 20152:03 pmRNSHolding(s) in Company
10th Apr 201511:05 amRNSHolding(s) in Company
8th Apr 20157:00 amRNSDELISTING FROM ALTERNEXT AMSTERDAM
19th Mar 20157:00 amRNSFinal Results
20th Feb 20157:00 amRNSSopheon Releases Accolade® 9.3
5th Feb 20154:12 pmRNSChange of Registered Office
28th Jan 20157:00 amRNSTrading Update
19th Dec 201410:30 amRNSResult of General Meeting
12th Dec 20143:00 pmRNSTrading Update
2nd Dec 20144:00 pmRNSProposed Share Subdivision
2nd Dec 20147:00 amRNSDirector/PDMR Shareholding
27th Oct 20144:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20143:45 pmRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSDirector/PDMR Shareholding
17th Oct 20141:50 pmRNSDirector/PDMR Shareholding
10th Oct 201411:15 amRNSResult of GM and Further re Share Consolidation
24th Sep 20147:00 amRNSAccolade 9.2 Release
12th Sep 20147:00 amRNSShare Consolidation
28th Aug 20147:00 amRNSHalf Yearly Report
11th Jun 201412:20 pmRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
2nd Jun 20147:00 amRNSAmendment To The Terms Of Convertible Loan Stock
22nd May 20147:00 amRNSAlternext Amsterdam
1st May 20147:00 amRNSInterim Management Statement
22nd Apr 20147:01 amRNSSopheon Delivers Accolade Release 9.1
11th Apr 20147:00 amRNSWind Down Of Alternext Amsterdam
20th Mar 20147:01 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results
6th Mar 20147:00 amRNSNew Debt Facility
29th Jan 20148:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.